Review By Dilip Davda on August 25, 2025
• The company is engaged in solvent recovery and recycling services and trading.
• It posted growth in its top and bottom lines for the reported periods.
• The sudden boost in bottom lines for FY25 raise eyebrows and concern over its sustainability going forward.
• The company is operating in a highly competitive and fragmented segment.
• Based on its recent financial data, the issue appears aggressively priced.
• There is no harm in skipping this pricey bet.
ABOUT COMPANY:
Snehaa Organics Ltd. (SOL) operates in the solvent recovery and recycling sector, providing sustainable solutions for industries that utilize solvents in their processes. The company collects spent solvents from various industries and employs distillation and purification technologies to process them for reuse. Company’s workforce ensures efficient recovery from diverse solvent mixtures, including those with significant variability between batches. Each batch undergoes comprehensive quality control measures to align with industry requirements.
The company also maintains a testing facility to address specific customer needs. The recovered solvents are returned to the respective companies for reuse, while the additional purified solvents are sold in the market, supporting resource efficiency and waste reduction. Additionally, the company engages in direct trading of solvent, sourcing raw materials from suppliers, conducting quality assessments, and sold them in the open market. As of July 31, 2025, it had 59 employees on its payroll.
ISSUE DETAILS/CAPITAL HISTORY:
The company is coming out with its maiden book-building route IPO of 2679000 equity shares of Rs. 10 each to mobilize Rs. 32.68 cr. at the upper cap. It has announced the price band of Rs. 115 – Rs. 122 per share. IPO opens for subscription on August 29, 2025, and will close on September 02, 2025. The minimum application to be made is for 2000 shares and in multiple of 1000 shares thereon, thereafter. Post allotment, shares will be listed on NSE SME Emerge. The issue constitutes 26.32% of post-IPO paid-up equity capital of the company. From the net proceeds of the issue, the company will utilize Rs. 3.50 cr. for repayment of loans, Rs. 23.94 cr. for working capital, and the rest for general corporate purposes.
The IPO is solely lead managed by Fast Track Finsec Pvt. Ltd., while Skyline Financial Services Pvt. Ltd. is the registrar to the issue. Nirman Share Brokers Pvt. Ltd. is the market maker.
The company has issued entire initial equity shares at par, and issued bonus shares in the ratio of 6.5 for 1 in December 2024. The average cost of acquisition of shares by the promoters/selling stakeholders is Rs. 1.07 per share.
Post-IPO, company’s current paid-up equity capital of Rs. 7.50 cr. will stand enhanced to Rs. 10.18 cr. Based on the upper price band of the IPO, the company is looking for a market cap of Rs. 124.18 cr.
FINANCIAL PERFORMANCE:
On the financial performance front, for the last three fiscals, the company has posted total Income/Net Profit of Rs. 20.41 cr. / Rs. 3.25 cr. (FY23- two broker periods), Rs. 23.8 cr. / Rs. 3.66 cr. (FY24), and Rs. 26.30 cr. / Rs. 7.34 cr. (FY25). Boosted profits for FY25 raise eyebrows and concern over its sustainability.
For the last three fiscals, the company has reported an average EPS of Rs. 7.31, and an average RoNW of 55.55%. The issue is priced at a P/BV of 6.19 based on its NAV of Rs. 19.70 as of March 31, 2025, but its post-IPO NAV data info is missing from offer documents.
If we attribute its FY25 super earnings on post-IPO expanded equity base, then the asking price is at a P/E of 16.92, and based on its FY24 earnings, the P/E stands at 38.89. Thus, based on its recent financial data, the issue appears aggressively priced.
The company has posted PAT margins of 7.26%+20.35% (FY23- two broker periods), 15.43% (FY24), 27.98% (FY25), and RoCE Margins of 14.36% + 50.33%, 46.70%, 50.38%, respectively for the referred periods.
DIVIDEND POLICY:
The company has not declared any dividends for the referred periods of the offer document. It will adopt a prudent dividend policy, based on its financial performances and future prospects.
COMPARISON WITH LISTED PEERS:
As per offer document, the company has no listed peers to compare with.
MERCHANT BANKER’S TRACK RECORDS:
This is the 19th mandate from Fast Track Finsec in the last eight fiscals (including the ongoing one). Out of the last 18 listings, 5 opened at discount, and the rest with premium ranging from 0.83% to 201.21% on the date of listing.
Review By Dilip Davda on August 25, 2025
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. My reviews do not cover GMP market and operators game plans. Readers must consult a qualified financial advisor before making any actual investment decisions, based the on information published here. With entry barriers, SEBI wants only well-informed investors to participate in such offers. With crazy listings in the recent past, SME IPOs drew the attention of investors across the board and lead to seer madness. However, as SME issues have entry barriers and continued low preference from the broking community, any reader taking decisions based on any information published here does so entirely at their own risk. The above information is based on information available as of date coupled with market perceptions. The Author has no plans to invest in this offer.
About Dilip Davda
Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.
Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detailed fundamental and financial analysis of companies coming up with IPOs helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.
(Dilip Davda -SEBI registered Research Analyst-Mumbai,
Registration no. INH000003127 (Perpetual)
Email id: dilip_davda@rediffmail.com ).
The initial public offer (IPO) of Snehaa Organics Ltd. offers an early investment opportunity in Snehaa Organics Ltd.. A stock market investor can buy Snehaa Organics IPO shares by applying in IPO before Snehaa Organics Ltd. shares get listed at the stock exchanges. An investor could invest in Snehaa Organics IPO for short term listing gain or a long term.
Read the Snehaa Organics IPO recommendations by the leading analyst and leading stock brokers.
Snehaa Organics IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the Snehaa Organics IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts mentioned in the above answer to "How is Snehaa Organics IPO?"
Sorry, we didn't rate the Snehaa Organics IPO.
Our lead analyst Mr. Dilip Davda didn't rate the Snehaa Organics IPO.
The Snehaa Organics IPO allotment status will be available on or around September 3, 2025. The allotted shares will be credited in demat account by September 4, 2025. Visit Snehaa Organics IPO allotment status to check.
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O